Cocrystal Property Plant And Equipment Gross vs Other Current Assets Analysis
COCP Stock | USD 2.13 0.23 12.11% |
Cocrystal Pharma financial indicator trend analysis is way more than just evaluating Cocrystal Pharma prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cocrystal Pharma is a good investment. Please check the relationship between Cocrystal Pharma Property Plant And Equipment Gross and its Other Current Assets accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.
Property Plant And Equipment Gross vs Other Current Assets
Property Plant And Equipment Gross vs Other Current Assets Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cocrystal Pharma Property Plant And Equipment Gross account and Other Current Assets. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Cocrystal Pharma's Property Plant And Equipment Gross and Other Current Assets is -0.01. Overlapping area represents the amount of variation of Property Plant And Equipment Gross that can explain the historical movement of Other Current Assets in the same time period over historical financial statements of Cocrystal Pharma, assuming nothing else is changed. The correlation between historical values of Cocrystal Pharma's Property Plant And Equipment Gross and Other Current Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Gross of Cocrystal Pharma are associated (or correlated) with its Other Current Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Assets has no effect on the direction of Property Plant And Equipment Gross i.e., Cocrystal Pharma's Property Plant And Equipment Gross and Other Current Assets go up and down completely randomly.
Correlation Coefficient | -0.01 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Property Plant And Equipment Gross
Other Current Assets
Assets expected to be converted into cash, sold, or consumed either in one year or in the operating cycle, which are not included under standard current asset categories.Most indicators from Cocrystal Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cocrystal Pharma current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.At this time, Cocrystal Pharma's Enterprise Value Over EBITDA is relatively stable compared to the past year. As of 05/23/2024, Enterprise Value Multiple is likely to grow to 0.37, while Selling General Administrative is likely to drop 5,690.
2023 | 2024 (projected) | Non Recurring | 41.5M | 36.9M | Reconciled Depreciation | 412K | 302.2K |
Cocrystal Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Cocrystal Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Cocrystal Pharma fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 28.5M | 54.2M | 79.4M | 40.8M | 31.3M | 29.7M | |
Total Current Liabilities | 2.3M | 1.4M | 1.5M | 1.2M | 3.3M | 2.7M | |
Total Stockholder Equity | 25.7M | 52.5M | 77.5M | 39.6M | 26.4M | 42.6M | |
Net Debt | (6.6M) | (32.4M) | (58.2M) | (36.8M) | (24.6M) | (23.3M) | |
Retained Earnings | (235.3M) | (244.9M) | (259.1M) | (297.9M) | (315.9M) | (300.1M) | |
Accounts Payable | 1.5M | 657K | 578K | 614K | 1.2M | 931.8K | |
Cash | 7.4M | 33.0M | 58.7M | 37.1M | 26.4M | 27.7M | |
Non Current Assets Total | 20.3M | 20.2M | 20.1M | 662K | 2.2M | 2.1M | |
Non Currrent Assets Other | (293K) | 40K | 50K | 46K | 46.0K | 48.3K | |
Cash And Short Term Investments | 7.4M | 33.0M | 58.7M | 37.1M | 26.4M | 27.7M | |
Common Stock Total Equity | 24K | 30K | 36K | 71K | 81.7K | 152.4K | |
Common Stock Shares Outstanding | 31.9M | 55.2M | 88.4M | 8.1M | 9.7M | 13.1M | |
Liabilities And Stockholders Equity | 28.5M | 54.2M | 79.4M | 40.8M | 31.3M | 29.7M | |
Other Stockholder Equity | 260.9M | 297.3M | 336.5M | 337.5M | 342.3M | 359.4M | |
Total Liab | 2.8M | 1.7M | 1.8M | 1.3M | 4.9M | 4.6M | |
Total Current Assets | 8.3M | 34.0M | 59.3M | 40.2M | 29.1M | 30.5M | |
Common Stock | 36K | 71K | 98K | 8K | 10K | 9.5K | |
Other Current Liab | 7K | 61K | 12K | 362K | 1.8M | 1.7M | |
Property Plant And Equipment Net | 1.1M | 1.1M | 931K | 616K | 2.1M | 2.2M | |
Other Current Assets | 169K | 399K | 568K | 2.2M | 1.8M | 930.3K | |
Property Plant And Equipment Gross | 1.1M | 1.1M | 2.4M | 2.2M | 3.9M | 4.1M | |
Short Long Term Debt Total | 817K | 596K | 534K | 297K | 1.9M | 1.6M | |
Non Current Liabilities Total | 537K | 379K | 298K | 57K | 1.6M | 1.5M | |
Short Term Debt | 280K | 217K | 236K | 240K | 216K | 205.2K | |
Net Tangible Assets | 6.6M | 33.4M | 58.5M | 39.6M | 35.6M | 34.6M | |
Other Assets | 50K | 544K | 46K | 0.0 | 1.0 | 0.95 | |
Retained Earnings Total Equity | (138.0M) | (187.1M) | (235.3M) | (244.9M) | (220.4M) | (209.4M) | |
Capital Surpluse | 243.4M | 253.9M | 260.9M | 297.3M | 341.9M | 215.9M | |
Property Plant Equipment | 1.1M | 1.1M | 931K | 616K | 708.4K | 640.6K | |
Net Invested Capital | 25.7M | 52.5M | 77.5M | 39.6M | 26.4M | 45.1M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cocrystal Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Cocrystal Stock, please use our How to Invest in Cocrystal Pharma guide.Note that the Cocrystal Pharma information on this page should be used as a complementary analysis to other Cocrystal Pharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Complementary Tools for Cocrystal Stock analysis
When running Cocrystal Pharma's price analysis, check to measure Cocrystal Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cocrystal Pharma is operating at the current time. Most of Cocrystal Pharma's value examination focuses on studying past and present price action to predict the probability of Cocrystal Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cocrystal Pharma's price. Additionally, you may evaluate how the addition of Cocrystal Pharma to your portfolios can decrease your overall portfolio volatility.
Global Correlations Find global opportunities by holding instruments from different markets | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Commodity Directory Find actively traded commodities issued by global exchanges | |
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |
Is Cocrystal Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cocrystal Pharma. If investors know Cocrystal will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cocrystal Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.87) | Revenue Per Share 0.006 | Quarterly Revenue Growth 0.269 | Return On Assets (0.37) | Return On Equity (0.55) |
The market value of Cocrystal Pharma is measured differently than its book value, which is the value of Cocrystal that is recorded on the company's balance sheet. Investors also form their own opinion of Cocrystal Pharma's value that differs from its market value or its book value, called intrinsic value, which is Cocrystal Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cocrystal Pharma's market value can be influenced by many factors that don't directly affect Cocrystal Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cocrystal Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cocrystal Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cocrystal Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.